Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
The return on assets (ROA) is -33.22%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -7.20%.
RETURN ON ASSETS (ROA)
-33.22%
RETURN ON ASSETS (ROA) AVG TTM
N/A
RETURN ON ASSETS (ROA) AVG 3Y
N/A
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-3.04%
vs the sector median at left
Atrium Therapeutics, Inc.
Market Cap
$136.50M
Return on Assets (ROA)
-33.22%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$136.57M
Return on Assets (ROA)
10.55%
TTM Avg
-7.15%
3Y Avg
-30.40%
5Y Avg
-23.45%
Market Cap
$138.03M
Return on Assets (ROA)
-6.51%
TTM Avg
-15.82%
3Y Avg
-25.09%
5Y Avg
-19.08%
Market Cap
$138.38M
Return on Assets (ROA)
-36.33%
TTM Avg
-27.39%
3Y Avg
-256.74%
5Y Avg
-207.88%
Market Cap
$140.13M
Return on Assets (ROA)
-28.35%
TTM Avg
-69.97%
3Y Avg
-58.34%
5Y Avg
-49.63%
Market Cap
$139.96M
Return on Assets (ROA)
-92.89%
TTM Avg
-84.34%
3Y Avg
-55.16%
5Y Avg
-43.29%
Market Cap
$131.30M
Return on Assets (ROA)
-35.50%
TTM Avg
-18.07%
3Y Avg
-62.20%
5Y Avg
-134.72%
Market Cap
$131.53M
Return on Assets (ROA)
-73.85%
TTM Avg
-21.75%
3Y Avg
-19.65%
5Y Avg
-19.48%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | $136.50M | -33.22% | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $136.57M | 10.55% | -7.15% | -30.40% | -23.45% |
| KORU Medical Systems, Inc. (KRMD)vs › | $138.03M | -6.51% | -15.82% | -25.09% | -19.08% |
| Alpha Cognition Inc (ACOG)vs › | $138.38M | -36.33% | -27.39% | -256.74% | -207.88% |
| Immuneering Corporation (IMRX)vs › | $140.13M | -28.35% | -69.97% | -58.34% | -49.63% |
| Sutro Biopharma, Inc. (STRO)vs › | $139.96M | -92.89% | -84.34% | -55.16% | -43.29% |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $131.30M | -35.50% | -18.07% | -62.20% | -134.72% |
| Health Catalyst, Inc. (HCAT)vs › | $131.53M | -73.85% | -21.75% | -19.65% | -19.48% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $130.51M | -6.07% | -5.08% | -4.92% | -1.70% |
ROA
-33.2%
ROE
-43.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -27.55% |
